Community Health Systems, Inc. CYH R2K
Healthcare · Medical Care Facilities · United States
Community Health Systems, Inc. owns, leases, and operates general acute care hospitals in the United States. The company offers general acute care, emergency room, general and specialty surgery, critical care, internal medicine, obstetrics, diagnostic, psychiatric, and rehabilitation services, as well as skilled nursing and home care services. It also provides outpatient services at primary care practices, urgent care centers, free-standing emergency departments, ambulatory surgery centers, imaging and diagnostic centers, and direct-to-consumer virtual health visits. Community Health Systems, Inc. was founded in 1985 and is headquartered in Franklin, Tennessee.
READ MORE ›$2.72
-29.90% 1Y
Market & Price
Market Cap
$383.29M
Current Price
$2.72
High / Low (52W)
$4.41 / $2.44
Beta
1.89
Valuation
Stock P/E
0.79
Industry PE
23.65
Forward P/E
25.45
PEG Ratio
2.38
Book Value
$-10.73
Price to Book
-0.25
P/S
0.03
EV/EBITDA
7.87
Dividend Yield
-
Profitability & Returns
ROCE
14.51%
ROE
-
ROA
4.68%
Profit Margin
3.78%
Op Margin
6.44%
EPS (Latest Qtr)
$-0.43
EPS (TTM)
$3.44
Balance Sheet & Liquidity
Debt/Equity
-
Quick Ratio
1.19
Current Ratio
1.47
Debt
$10.76B
Total Assets
$13.20B
Current Assets
$3.23B
Working Capital
$1.03B
Ownership
Promoter Holding
15.19%
Chg in Prom Hold
-
FII / Inst Holding
78.72%
Chg in FII Hold
-
Financial Snapshot
Enterprise Value
$10.90B
Total Revenue (TTM)
$12.29B
EBITDA
$1.39B
Free Cash Flow
$337.88M
Operating Cash Flow
$126.00M
Shares Outstanding
140.92M
Gross Margin
41.60%
Payout Ratio
0.00%
Growth (CAGR)
Revenue 5Y
0.74%
Profit 5Y
122.84%
Revenue (YoY)
-6.10%
Earnings (YoY)
-
PROS
- Profit CAGR of 122.8% over 5 years.
- Generates positive free cash flow.
CONS
- Trading 38.3% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth
No fundamental data available for this stock.
Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).
Peer comparison
Peer companies in the same sector (Healthcare).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | CYH Community Health Systems, Inc. R2K | 2.72 | 0.79 | $383.29M | - | 14.51% | - | 0.74% | 122.84% |
| 2 | LLY Eli Lilly and Company SPX | 1,105.00 | 39.21 | $985.37B | 0.63% | 38.44% | 107.46% | 31.69% | 48.96% |
| 3 | JNJ Johnson & Johnson SPX | 225.33 | 26.11 | $542.42B | 2.38% | 23.13% | 26.42% | 5.60% | 14.32% |
| 4 | UNH UnitedHealth Group Incorporated SPX | 380.31 | 28.66 | $345.38B | 2.32% | 9.60% | 12.18% | 11.35% | -15.69% |
| 5 | MRK Merck & Co., Inc. SPX | 118.72 | 33.44 | $293.22B | 2.86% | 20.66% | 18.94% | 3.12% | 7.93% |
| 6 | TMO Thermo Fisher Scientific Inc. SPX | 492.51 | 27.11 | $183.03B | 0.38% | 9.17% | 13.52% | -0.27% | -1.19% |
| 7 | AMGN Amgen Inc. NDXSPX | 336.79 | 23.42 | $181.77B | 2.99% | 18.02% | 101.32% | 11.77% | 5.58% |
| 8 | GILD Gilead Sciences, Inc. NDXSPX | 134.43 | 18.29 | $166.90B | 2.44% | 22.92% | 43.36% | 2.57% | 22.83% |
| 9 | ISRG Intuitive Surgical, Inc. NDXSPXAI | 424.64 | 51.53 | $150.39B | - | 15.96% | 17.23% | 17.39% | 29.26% |
Ad space
Quarterly Results
Figures in USD.
| Metric | Jun 2015 | Sep 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | 4.49B | 4.14B | 3.67B | 3.06B | 3.69B | 3.56B | 3.45B | 3.45B | 3.38B | 3.30B | 3.25B | 3.29B | 3.02B | 2.52B | 3.13B | 3.01B | 3.01B | 3.12B | 3.11B | 2.93B | 3.02B | 3.11B | 3.12B | 3.09B | 3.14B | 3.14B | 3.09B | - | 3.16B | 3.13B | 3.09B | 3.11B | 2.96B |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 489.00M | 469.00M | 460.00M | 446.00M | 441.00M |
| Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.67B | 2.66B | 2.63B | 2.66B | 2.52B |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.41B | 2.39B | 2.36B | 2.37B | 2.33B |
| Operating Income | 441.00M | 351.00M | - | 294.00M | -1.38B | 146.00M | - | 71.00M | 113.00M | 90.00M | - | 212.00M | 37.00M | 74.00M | - | 189.00M | 111.00M | 184.00M | - | 110.00M | 296.00M | 285.00M | 326.00M | 314.00M | 340.00M | 270.00M | 119.00M | 204.00M | 210.00M | 246.00M | 173.00M | 231.00M | 238.00M | -205.00M | - | 260.00M | 273.00M | 264.00M | 286.00M | 191.00M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 391.00M | 758.00M | 322.00M | 553.00M | 391.00M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 219.00M | 214.00M | 216.00M | 223.00M | 213.00M |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 67.00M | 438.00M | -2.00M | 221.00M | 64.00M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 42.00M | 118.00M | -173.00M | 61.00M | 89.00M |
| Net Income | 111.00M | 52.00M | -83.00M | 11.00M | -1.43B | -79.00M | -220.00M | -199.00M | -137.00M | -110.00M | -2.01B | -25.00M | -110.00M | -325.00M | -328.00M | -118.00M | -167.00M | -17.00M | -373.00M | 18.00M | 70.00M | 112.00M | -64.00M | 6.00M | 111.00M | -1.00M | -326.00M | -42.00M | -51.00M | -38.00M | -91.00M | -41.00M | -13.00M | -391.00M | - | -13.00M | 282.00M | 130.00M | 110.00M | -58.00M |
| Diluted EPS | 0.95 | 0.44 | -0.73 | 0.10 | -12.91 | -0.71 | -1.99 | -1.79 | -1.22 | -0.98 | -17.98 | -0.22 | -0.97 | -2.88 | -2.91 | -1.04 | -1.47 | -0.15 | -3.27 | 0.15 | 0.61 | 0.97 | -0.51 | 0.04 | 0.85 | -0.01 | -2.52 | -0.32 | -0.40 | -0.29 | -0.69 | -0.32 | -0.10 | -2.95 | - | -0.10 | 2.09 | 0.96 | 0.81 | -0.43 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | 18.44B | 15.35B | 14.15B | 13.21B | 11.79B | - | 12.21B | 12.49B | 12.63B | 12.48B |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.98B | 1.99B | 1.95B | 1.86B |
| Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 10.24B | 10.50B | 10.69B | 10.62B |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 9.52B | 9.63B | 9.85B | 9.54B |
| Operating Income | 971.88M | 1.06B | 1.12B | 1.13B | 1.23B | 917.00M | 1.34B | 1.34B | -860.00M | -1.88B | 208.00M | 650.00M | 1.13B | - | 719.00M | 870.00M | 843.00M | 1.08B |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.74B | 1.54B | 1.07B | 2.02B |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 860.00M | 832.00M | 863.00M | 872.00M |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 349.00M | 207.00M | -283.00M | 724.00M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 170.00M | 191.00M | 79.00M | 48.00M |
| Net Income | 218.30M | 243.15M | 279.98M | 201.95M | 266.00M | 141.00M | 92.00M | 158.00M | -1.72B | -2.46B | -788.00M | -675.00M | 511.00M | - | 46.00M | -133.00M | -516.00M | 509.00M |
| Diluted EPS | 2.32 | 2.66 | 3.01 | 2.23 | 2.96 | 1.51 | 0.82 | 1.37 | -15.54 | -22.00 | -6.99 | -5.93 | 4.39 | - | 0.35 | -1.02 | -3.90 | 3.77 |
Compounded Sales Growth
| 5 Years: | 0.74% |
| 1 Year: | -6.10% |
Compounded Profit Growth
| 5 Years: | 122.84% |
| 1 Year: | - |
Stock Price Performance
| 1 Year: | -29.90% |
| 6 Months: | -21.61% |
| 3 Months: | -21.39% |
| 1 Month: | -5.23% |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | - | 14.02B | 14.70B | 15.21B | 16.61B | 17.12B | 27.42B | 26.59B | 21.94B | 17.45B | 15.86B | 15.61B | 16.01B | 15.22B | 14.67B | 14.46B | 14.05B | 13.20B |
| Current Assets | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 3.08B | 3.21B | 3.30B | 3.23B |
| Cash & Equivalents | 133.57M | 220.66M | 344.54M | 299.17M | 130.00M | 388.00M | 373.00M | 509.00M | 184.00M | 238.00M | 563.00M | 196.00M | 216.00M | 1.68B | 507.00M | 118.00M | 38.00M | 37.00M | 260.00M |
| Inventory | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 353.00M | 328.00M | 331.00M | 322.00M |
| Receivables | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.04B | 2.23B | 2.29B | 2.08B |
| Total Liabilities | - | - | 11.64B | 12.06B | 12.35B | 13.44B | 13.63B | 22.81B | 21.92B | 19.66B | 17.61B | 16.82B | 17.25B | 17.06B | 16.03B | 15.40B | 15.28B | 15.37B | 14.04B |
| Current Liabilities | - | - | 1.46B | 1.64B | 1.91B | 2.14B | 2.46B | 3.59B | 3.07B | 2.89B | 2.36B | 2.39B | 2.28B | 2.81B | 2.36B | 2.19B | 2.14B | 2.35B | 2.21B |
| Long Term Debt | - | - | - | - | - | - | - | - | - | - | - | 13.39B | 13.38B | 12.09B | 12.11B | 11.61B | 11.47B | 11.43B | 10.38B |
| Total Debt | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 12.39B | 12.17B | 12.10B | 11.04B |
| Total Equity | - | - | 1.95B | 2.19B | 2.40B | 2.73B | 3.07B | 4.00B | 4.02B | 1.61B | -767.00M | -1.53B | -2.22B | -1.62B | -1.37B | -1.37B | -1.39B | -1.91B | -1.39B |
| Shares Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 134.70M | 136.77M | 138.92M | 138.63M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.06B | 1.08B | 1.19B | 1.26B | 1.28B | 1.09B | 1.61B | 921.00M | 1.14B | 773.00M | 274.00M | 385.00M | 2.18B | - | 300.00M | 210.00M | 480.00M | 543.00M |
| Investing Cash Flow | -665.47M | -867.18M | -1.04B | -1.20B | -1.38B | -991.00M | -4.35B | -1.05B | 630.00M | 1.07B | -245.00M | -2.00M | 177.00M | - | -259.00M | -26.00M | -275.00M | 847.00M |
| Financing Cash Flow | -304.03M | -85.36M | -189.79M | -235.44M | 361.00M | -113.00M | 2.87B | -195.00M | -1.71B | -1.52B | -396.00M | -363.00M | -895.00M | - | -430.00M | -264.00M | -206.00M | -1.17B |
| Capital Expenditure | -692.23M | -576.89M | -667.38M | -776.71M | -769.00M | -614.00M | -853.00M | -953.00M | -744.00M | -564.00M | -527.00M | -438.00M | -440.00M | - | -415.00M | -467.00M | -360.00M | -335.00M |
| Free Cash Flow | 364.35M | 499.54M | 521.35M | 485.19M | 511.00M | 475.00M | 762.00M | -32.00M | 393.00M | 209.00M | -253.00M | -53.00M | 1.74B | - | -115.00M | -257.00M | 120.00M | 208.00M |
| Net Change in Cash | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -389.00M | -80.00M | -1.00M | 223.00M |
| Share Buybacks | 90.19M | - | 113.96M | 85.79M | - | 27.00M | 9.00M | 159.00M | - | - | - | - | - | - | - | - | - | - |
Ratios (Annual)
Figures in %.
| Metric | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 83.8% | 84.0% | 84.6% | 85.1% |
| Operating Margin % | - | - | - | - | - | - | - | - | -4.7% | -12.2% | 1.5% | 4.9% | 9.6% | - | 5.9% | 7.0% | 6.7% | 8.7% |
| Net Margin % | - | - | - | - | - | - | - | - | -9.3% | -16.0% | -5.6% | -5.1% | 4.3% | - | 0.4% | -1.1% | -4.1% | 4.1% |
| ROE % | - | 12.5% | 12.8% | 8.4% | 9.7% | 4.6% | 2.3% | 3.9% | -106.6% | 320.6% | 51.3% | 30.4% | -31.4% | - | -3.4% | 9.6% | 27.0% | -36.5% |
| ROCE % | - | 8.5% | 8.6% | 8.5% | 8.5% | 6.3% | 5.6% | 5.7% | -4.5% | -12.4% | 1.5% | 4.9% | 8.5% | - | 5.8% | 7.1% | 7.2% | 9.8% |
Shareholding Pattern
Insiders
15.19%
Institutions
78.72%
Public Float
92.82%
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Castleknight Management LP | 8.99% | 12.67M | $34.46M |
| 2 | Apollo Management Holdings, L.P. | 8.15% | 11.49M | $31.25M |
| 3 | Blackrock Inc. | 6.96% | 9.80M | $26.66M |
| 4 | Eversept Partners, LP | 6.16% | 8.68M | $23.60M |
| 5 | Nomura Holdings Inc. | 4.89% | 6.89M | $18.73M |
| 6 | Vanguard Capital Management LLC | 3.81% | 5.38M | $14.62M |
| 7 | Whitebox Advisors, LLC | 2.22% | 3.13M | $8.51M |
| 8 | Two Sigma Investments, LP | 2.13% | 3.00M | $8.16M |
| 9 | Vanguard Portfolio Management LLC | 2.12% | 2.99M | $8.14M |
| 10 | State Street Corporation | 2.07% | 2.92M | $7.95M |
Analyst View
Loading analyst coverage…
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for CYH
No recent headlines available.